Enhancing primary newborn screening efficiency for congenital adrenal hyperplasia with LC-MS/MS/MS
Clinica Chimica Acta · 2026
DOI: 10.1016/j.cca.2025.120482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2026. Verfasst von Alexander Gaudl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, Leipzig University Medical Center, Leipzig, Germany. Electronic addr…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Tandem Mass Spectrometry, Neonatal Screening. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Newborn screening (NBS) for congenital adrenal hyperplasia (CAH) by immunoassay (IA) suffers from analytical limitations like cross reactivity and matrix effects. Alternative tandem-mass spectrometric approaches are not suitable for high-throughput screening due to long analysis times. In this study, a rapid 1.5 min LC-MS/MS/MS (MS3) assay was applied for the first time, maturity-dependent cutoffs were determined, and the diagnostic efficiency was compared to IA for primary CAH NBS. METHODS: 1730 selected residual dried blood samples from routine NBS (gestation week 24-41) were subjected to online-SPE-LC-MS3 quantitation of 17-Hydroxyprogesterone (17-OHP). This approach utilizes two-stage fragmentation (MS3, 17-OHP m/z 329/285/123) carried out by triple quadrupole-ion trap hybrid MS. Cutoff values were calculated depending on gestational age (GA) and birthweight (BW). Diagnostic efficiency was compared to an established IA for primary CAH screening. RESULTS: Intermediate precision was 10-13 % with an accuracy of 99-101 % (n = 50). Cutoff values based on GA as well as BW decreased with increasing maturity and weight of the newborns, ranging from 136 nmol/L whole blood for extreme preterm babies to 15 nmol/L whole blood for term babies. Combining LC-MS3 with GA- and BW-dependent cutoffs reduced the number of false-positive results from 731 to 15, while identifying all confirmed cases of CAH. CONCLUSION: By application of LC-MS3 and the combinatory cutoff approach, the positive predictive value for CAH-screening improved from 1% to 32%, presenting a major benefit in diagnostic efficiency over the commonly applied IA strategy. This underlines the potential of MS3 technology in clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, Leipzig University Medical Center, Leipzig, Germany. Electronic address: alexander.gaudl@medizin.uni-leipzig.de.
- Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, Leipzig University Medical Center, Leipzig, Germany.
Zitieren
APA
Gaudl, A., Lehmicke, L., Biemann, R., Dittrich, J., & Ceglarek, U. (2026). Enhancing primary newborn screening efficiency for congenital adrenal hyperplasia with LC-MS/MS/MS. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2025.120482
Vancouver
Gaudl A, Lehmicke L, Biemann R, Dittrich J, Ceglarek U. Enhancing primary newborn screening efficiency for congenital adrenal hyperplasia with LC-MS/MS/MS. Clinica Chimica Acta. 2026. doi:10.1016/j.cca.2025.120482
BibTeX
@article{Gaudl2026,
author = {Gaudl, Alexander and Lehmicke, Laura and Biemann, Ronald and Dittrich, Julia and Ceglarek, Uta},
title = {Enhancing primary newborn screening efficiency for congenital adrenal hyperplasia with LC-MS/MS/MS},
journal = {Clinica Chimica Acta},
year = {2026},
doi = {10.1016/j.cca.2025.120482}
}
EUVIMED